US Stock Market Movement: ORIC Pharmaceuticals Surges on October 20 Due to ESMO+ Clinical Oncology Drug

ORIC Pharmaceuticals Soars on October 20: Analysis

Keywords: ESMO, Clinical Oncology Drug

On October 19, the company announced that it will hold a conference call and webcast at 8:00 a.m. ET on October 23 to review enozertinib clinical data that will be presented at the 2026 ESMO conference. Dr. Joshua Sabari will discuss the potential of this drug for treatment-naïve NSCLC patients with EGFR uncommon mutations.

(Disclaimer: This content is collected and compiled by AI technology from public information and is for reference only. It does not constitute investment advice.)